Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleThe State of the Art

Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances

Amr Mohamed and Jonathan R. Strosberg
Journal of Nuclear Medicine June 2019, 60 (6) 721-727; DOI: https://doi.org/10.2967/jnumed.118.214882
Amr Mohamed
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan R. Strosberg
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 6 721-727
DOI 
https://doi.org/10.2967/jnumed.118.214882
PubMed 
30737297

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication November 26, 2018
  • Accepted for publication January 13, 2019
  • Published online June 3, 2019.

Article Versions

  • previous version (February 8, 2019 - 14:40).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Amr Mohamed and
  2. Jonathan R. Strosberg
  1. H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida
  1. For correspondence or reprints contact: Jonathan R. Strosberg, Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Dr., Tampa, FL 33612. E-mail: jonathan.strosberg{at}moffitt.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • 16 Citations
  • 17 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine
    Guido Rindi, Bertram Wiedenmann
    Nature Reviews Endocrinology 2020 16 10
  • The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
    Philip E. Harris, Konstantin Zhernosekov
    Frontiers in Endocrinology 2022 13
  • ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner
    Jinhao Chen, Mujie Ye, Jianan Bai, Zhihui Gong, Lijun Yan, Danyang Gu, Chunhua Hu, Feiyu Lu, Ping Yu, Lin Xu, Yan Wang, Ye Tian, Qiyun Tang
    Journal of Translational Medicine 2023 21 1
  • Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum
    Alessandro Ottaiano, Mariachiara Santorsola, Francesco Perri, Ugo Pace, Bruno Marra, Marco Correra, Francesco Sabbatino, Marco Cascella, Nadia Petrillo, Monica Ianniello, Marika Casillo, Gabriella Misso, Paolo Delrio, Michele Caraglia, Guglielmo Nasti
    Biology 2022 11 2
  • Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients
    Yuqing Qu, Haoming Li, Xianling Wang, Yulong Chen, Qinghua Guo, Yu Pei, Jin Du, Jingtao Dou, Jianming Ba, Zhaohui Lv, Yiming Mu, Tatsuya Kin
    International Journal of Endocrinology 2020 2020
  • New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors
    Steven D. Scoville, Jordan M. Cloyd, Timothy M. Pawlik
    Expert Opinion on Pharmacotherapy 2020 21 2
  • Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRT
    Eva Medaer, Chris Verslype, Eric Van Cutsem, Jeroen Dekervel, Paul M. Clement, Kristiaan Nackaerts, Annouschka Laenen, Olivier Gheysens, Karolien Goffin, Sander Jentjens, Koen Van Laere, Christophe M. Deroose
    Acta Oncologica 2020 59 6
  • Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
    Lingaku Lee, Irene Ramos-Alvarez, Robert T. Jensen
    Cancers 2022 14 5
  • Combined use of 177Lu‐DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well‐differentiated neuroendocrine tumors: A preclinical study
    Jingjing Fu, Fan Qiu, Cati Raluca Stolniceanu, Fei Yu, Shiming Zang, Yili Xiang, Yue Huang, Milovan Matovic, Cipriana Stefanescu, Qiyun Tang, Feng Wang
    Journal of Neuroendocrinology 2022 34 4
  • The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study
    Jon Arne Søreide, Jan Terje Kvaløy, Dordi Lea, Oddvar M. Sandvik, Mohammed Al‐Saiddi, Torjan M. Haslerud, Herish Garresori, Lars N. Karlsen, Einar Gudlaugsson, Kjetil Søreide
    Cancer Reports 2022 5 2

Article usage

Article usage: February 2019 to April 2025

AbstractFullPdf
Feb 2019539082
Mar 2019143029
Apr 201975018
May 201984018
Jun 2019213653227
Jul 20193261437
Aug 2019227720
Sep 2019106415
Oct 2019121416
Nov 201971414
Dec 2019621426
Jan 202057627
Feb 2020542016
Mar 2020473126
Apr 2020432222
May 2020633926
Jun 2020282627
Jul 2020461817
Aug 2020361624
Sep 2020382524
Oct 2020352623
Nov 2020361419
Dec 2020252113
Jan 2021112922
Feb 2021203525
Mar 2021212916
Apr 2021102314
May 2021193328
Jun 2021121711
Jul 2021144717
Aug 2021153822
Sep 2021113923
Oct 2021143933
Nov 202194136
Dec 202193013
Jan 2022132915
Feb 202272324
Mar 2022125741
Apr 2022154243
May 2022101416
Jun 202281517
Jul 20228169
Aug 202282319
Sep 2022141614
Oct 202272219
Nov 202262214
Dec 202282322
Jan 2023103213
Feb 20235137
Mar 2023132114
Apr 2023163217
May 202372213
Jun 202361614
Jul 202352018
Aug 202351918
Sep 20234169
Oct 202361212
Nov 202372111
Dec 20234259
Jan 2024193117
Feb 202442413
Mar 202482040
Apr 202483328
May 202434817
Jun 20248249
Jul 202472325
Aug 2024112727
Sep 202481917
Oct 202474318
Nov 2024131822
Dec 202431818
Jan 202561914
Feb 2025410014
Mar 202576931
Apr 2025155332
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (6)
Journal of Nuclear Medicine
Vol. 60, Issue 6
June 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances
Amr Mohamed, Jonathan R. Strosberg
Journal of Nuclear Medicine Jun 2019, 60 (6) 721-727; DOI: 10.2967/jnumed.118.214882

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances
Amr Mohamed, Jonathan R. Strosberg
Journal of Nuclear Medicine Jun 2019, 60 (6) 721-727; DOI: 10.2967/jnumed.118.214882
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • SSA THERAPY
    • TELOTRISTAT ETHYL
    • EVEROLIMUS
    • ANGIOGENESIS INHIBITORS
    • CYTOTOXIC CHEMOTHERAPY IN WELL-DIFFERENTIATED NETS
    • CYTOTOXIC CHEMOTHERAPY IN POORLY DIFFERENTIATED NECA
    • RADIOLABELED SSA THERAPY
    • LIVER-DIRECTED THERAPY
    • SELECTION AND SEQUENCING OF THERAPIES
    • FUTURE DIRECTIONS
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
  • Rethinking Dosimetry: A European Perspective
  • A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Show more The State of the Art

Similar Articles

Keywords

  • management
  • gastroenteropancreatic neuroendocrine tumors
  • carcinoid tumors
  • systemic treatment
SNMMI

© 2025 SNMMI

Powered by HighWire